The rapidly growing demand for pure and highly concentrated resveratrol represents an opportunity for our global brand partners. By leveraging the VESIsorb® delivery system, SourceOne offers the ultimate solution that ensures optimal bioavailability and absorption of resveratrol to achieve superior therapeutic benefits that include cellular and cardiovascular health as well as neurocognitive function and antioxidant defense.

Unfortunately, concentrated resveratrol products are poorly soluble and have limited absorption. To overcome these limitations, SourceOne utilizes the VESIsorb® delivery system which dramatically improves the pharmacokinetic parameters (Cmax, Tmax, and AUC) of resveratrol.

Improved bioavailability directly translates to delivering higher blood plasma levels with a much lower dose.

‍The benefits are unmatched:

- Faster onset, independent of food/fat status.

- Fewer servings required to achieved the desired therapeutic effect.

- Superior loading for smaller and easier to consumer capsules.

- Addressing issues related to poor absorption like age, diet, and gender.

Simply put, this formula delivers unmatched blood plasma levels of resveratrol in an elegant softgel capsule.

In a dissolution study, resveratrol with the VESIsorb® delivery system demonstrated 100% dissolution, the ability to dissolve readily in an aqueous environment for absorption, compared to less than 1% for powder.

In a 30-day, randomized double-blind crossover trial, 150 mg resVida® resveratrol supported a variety of cardio metabolic health markers. Resveratrol promoted AMPK activity and SIRT1 and PGC-1α protein levels, biomarkers that positively correlate with metabolic health and mitochondrial function. Resveratrol also promoted healthy blood flow, adipose tissue lipolysis and hepatic lipid content.